Method and apparatus for reducing intermodulation distortion in an electronic device having an amplifier circuit
    35.
    发明授权
    Method and apparatus for reducing intermodulation distortion in an electronic device having an amplifier circuit 有权
    用于减少具有放大器电路的电子设备中的互调失真的方法和装置

    公开(公告)号:US07656229B2

    公开(公告)日:2010-02-02

    申请号:US12021061

    申请日:2008-01-28

    IPC分类号: H03F3/38

    摘要: An electronic device includes an amplifier circuit coupled to a linearizer. The amplifier circuit may receive a first input signal including first and second frequencies and generate a first output signal including a delta frequency signal at a delta frequency, which is the difference between the first frequency and the second frequency. The linearizer includes a signal detector circuit, a current-mirror circuit, a low pass filter, a phase shifter, and a bias circuit. The signal detector circuit may generate a second output signal. The current-mirror circuit may adjust an amplitude of a signal. The low pass filter may eliminate a portion of the second output signal having frequencies greater than the delta frequency. The phase shifter may generate a feedback signal corresponding to the delta frequency signal. An amplitude and/or a phase of the feedback signal is different from an amplitude and/or a phase of the delta frequency signal.

    摘要翻译: 电子设备包括耦合到线性化器的放大器电路。 放大器电路可以接收包括第一和第二频率的第一输入信号,并产生第一输出信号,该第一输出信号包括第一频率和第二频率之间的差异的增量频率的增量频率信号。 线性化器包括信号检测器电路,电流镜电路,低通滤波器,移相器和偏置电路。 信号检测器电路可以产生第二输出信号。 电流镜电路可以调节信号的幅度。 低通滤波器可以消除具有大于Δ频率的频率的第二输出信号的一部分。 移相器可以产生对应于Δ频率信号的反馈信号。 反馈信号的幅度和/或相位与增量频率信号的振幅和/或相位不同。

    Triazoles as farnesyl transferase inhibitors
    36.
    发明授权
    Triazoles as farnesyl transferase inhibitors 有权
    三唑作为法呢基转移酶抑制剂

    公开(公告)号:US07592356B2

    公开(公告)日:2009-09-22

    申请号:US11926858

    申请日:2007-10-29

    IPC分类号: A61K31/47 C07D249/08

    摘要: a prodrug, N-oxide, addition salt, quaternary amine or stereochemically isomeric form thereof, wherein L1 and L2 are R1—Y— wherein each (R1—Y)— substituent is defined independently of the other; Y is C1-4alkanediyl, C2-4alkenediyl, C2-4alkynediyl, C(═O), or a direct bond; R1 is hydrogen, cyano, aryl or a substituted or unsubstituted C1-14heterocycle; ═Z1—Z2═Z3— represents a radical of formula ═N—N═CH— (a-1), ═N—CH═N— (a-2), ═CH—N═N— (a-3); X is SO2, (CH2), wherein n is 1 to 4, C(═O), C(═S), or a direct bond; R2 is aryl, C3-7cycloalkyl, C3-7cycloalkyl substituted with one or more substituents independently selected from hydroxy, aryl, aryloxy, a substituted or unsubstituted C1-14heterocycle, C3-7cycloalkyl, hydroxycarbonyl, C1-6alkyloxycarbonyl, hydroxyC1-6alkyl, hydroxyC1-6alkyloxy, hydroxyC1-6alkylthio and arylC1-6alkylthio, C1-12alkyl or C1-12alkyl substituted with one or more substituents independently selected from hydroxy, aryl, aryloxy, a substituted or unsubstituted C1-14heterocycle, C3-7cycloalkyl, hydroxycarbonyl, C1-6alkyloxycarbonyl, hydroxyC1-6alkyl, hydroxyC1-6alkyloxy, hydroxyC1-6alkylthio and arylC1-6alkylthio; R3 is aryl, —NR5R6, a substituted or unsubstituted C1-14heterocycle, or C2-4alkenediyl substituted with a substituted or unsubstituted C1-14heterocycle or aryl; R4 is hydrogen, aryl, C3-7cycloalkyl, C1-6alkyl or C1-6alkyl substituted with C3-7cycloalkyl, hydroxycarbonyl, C1-4alkyloxycarbonyl or aryl; R5 and R6 are each independently selected from hydrogen, a substituted or unsubstituted C1-14heterocycle, aryl, C1-12alkyl and C1-12alkyl substituted with one or more substituents selected from hydroxy, aryl, aryloxy or a substituted or unsubstituted C1-14heterocycle.

    摘要翻译: 前药,N-氧化物,加成盐,季胺或其立体化学异构形式,其中L 1和L 2是R 1 -Y-,其中每个(R 1 -Y) - 取代基独立地彼此定义; Y是C1-4烷二基,C2-4亚烯基,C2-4炔二基,C(-O)或直接键; R1是氢,氰基,芳基或取代或未取代的C1-14杂环; -Z1-Z2-Z3-表示式-N-N-CH-(a-1),-N-CH-N-(a-2),-CH-N-N-(a-3) X是SO 2,(CH 2),其中n是1至4,C(-O),C(-S)或直接键; R 2是芳基,C 3-7环烷基,被一个或多个独立地选自羟基,芳基,芳氧基,取代或未取代的C 1-14杂环,C 3-7环烷基,羟基羰基,C 1-6烷氧基羰基,羟基C 1-6烷基,羟基C 1-6烷基, 被一个或多个独立地选自羟基,芳基,芳氧基,取代或未取代的C 1-14杂环,C 3-7环烷基,羟基羰基,C 1-6烷氧基羰基,C 1-6烷氧基羰基,C 1-6烷硫基, 羟基C 1-6烷基,羟基C 1-6烷氧基,羟基C 1-6烷硫基和芳基C 1-6烷硫基; R3是芳基,-NR5R6,取代或未取代的C1-14杂环,或被取代或未取代的C1-14杂环或芳基取代的C2-4亚烯基; R4是氢,芳基,C3-7环烷基,C1-6烷基或被C3-7环烷基取代的C1-6烷基,羟基羰基,C1-4烷氧基羰基或芳基; R 5和R 6各自独立地选自氢,取代或未取代的C 1-14杂环,芳基,C 1-12烷基和被一个或多个选自羟基,芳基,芳氧基或取代或未取代的C 1-14杂环的取代基取代的C 1-12烷基。

    FREQUENT PATTERN ARRAY
    38.
    发明申请
    FREQUENT PATTERN ARRAY 有权
    常规图案阵列

    公开(公告)号:US20090171954A1

    公开(公告)日:2009-07-02

    申请号:US11965379

    申请日:2007-12-27

    申请人: Li Liu Qiang Li

    发明人: Li Liu Qiang Li

    IPC分类号: G06F17/30 G06F12/00

    CPC分类号: G06F17/30961

    摘要: Machine readable media, methods, and computing devices are disclosed that mine a dataset using a frequent pattern array. One method of includes building a frequent pattern tree comprising a plurality of nodes to represent frequent transactions of a dataset that comprises one or more items. The method also includes transforming the frequent pattern tree to a frequent pattern array that comprises an item array and a plurality of node arrays, the item array comprising frequent transactions of the dataset and each node array to associate an item of the dataset with one or more frequent transactions of the item array. The method further includes identifying frequent transactions of the dataset based upon the frequent pattern array.

    摘要翻译: 公开了使用频繁模式阵列挖掘数据集的机器可读介质,方法和计算设备。 一种方法包括构建包括多个节点的频繁模式树,以表示包括一个或多个项目的数据集的频繁事务。 该方法还包括将频繁模式树变换为包括项目数组和多个节点数组的频繁模式数组,所述项目数组包括数据集和每个节点数组的频繁事务以将数据集的项目与一个或多个 项目数组的频繁事务。 该方法还包括基于频繁模式阵列识别数据集的频繁事务。